BioSyent Inc. (V:RX*CA)

Business Focus: Pharmaceuticals (NEC)

Latest 10 SEDI filings (by transaction date) for RX*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 28/24 Mar 27/24 Wilson, Kevin Direct Ownership Common Shares 56 - Grant of rights 4,074  
Mar 27/24 Mar 27/24 Lockhard, Peter Douglas Direct Ownership Common Shares 56 - Grant of rights 5,173  
Mar 27/24 Mar 27/24 Elford, Sara Direct Ownership Rights Restricted Share Units 56 - Grant of rights 2,385  
Mar 27/24 Mar 27/24 March, Robert Joseph Direct Ownership Common Shares 56 - Grant of rights 6,631 $8.70
Mar 27/24 Mar 26/24 Lockhard, Peter Douglas Direct Ownership Common Shares 10 - Disposition in the public market -600 $8.70
Mar 27/24 Mar 24/24 Wilson, Kevin Direct Ownership Common Shares 57 - Exercise of rights 2,268 $8.50
Mar 27/24 Mar 20/24 Wilson, Kevin Direct Ownership Common Shares 57 - Exercise of rights -4,537  
Mar 25/24 Mar 19/24 van der Mark, Joost Direct Ownership Common Shares 57 - Exercise of rights 3,521  
Mar 25/24 Mar 19/24 van der Mark, Joost Direct Ownership Common Shares 57 - Exercise of rights -7,043  
Mar 21/24 Mar 19/24 Ashrafi, Seyed Ahmad Direct Ownership Common Shares 57 - Exercise of rights 2,268 $8.50
Sign up or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for RX*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 28/24 Mar 27/24 Wilson, Kevin Direct Ownership Common Shares 56 - Grant of rights 4,074  
Mar 27/24 Mar 27/24 Lockhard, Peter Douglas Direct Ownership Common Shares 56 - Grant of rights 5,173  
Mar 27/24 Mar 27/24 Elford, Sara Direct Ownership Rights Restricted Share Units 56 - Grant of rights 2,385  
Mar 27/24 Mar 27/24 March, Robert Joseph Direct Ownership Common Shares 56 - Grant of rights 6,631 $8.70
Mar 27/24 Mar 26/24 Lockhard, Peter Douglas Direct Ownership Common Shares 10 - Disposition in the public market -600 $8.70
Mar 27/24 Mar 24/24 Wilson, Kevin Direct Ownership Common Shares 57 - Exercise of rights 2,268 $8.50
Mar 27/24 Mar 20/24 Wilson, Kevin Direct Ownership Common Shares 57 - Exercise of rights -4,537  
Mar 27/24 Dec 31/23 Wilson, Kevin Direct Ownership Common Shares 30 - Acquisition under a purchase/ownership plan 281 $7.71
Mar 27/24 Dec 31/23 Wilson, Kevin Direct Ownership Common Shares 30 - Acquisition under a purchase/ownership plan 1,261 $7.75
Mar 25/24 Dec 31/23 Ashrafi, Seyed Ahmad Direct Ownership Common Shares 30 - Acquisition under a purchase/ownership plan 281 $7.71
Sign up or login above to see all SEDI filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider.
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $RX.CA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Cresco Labs (C:CL*CA)
Vitality Products (V:VPI*CA)
Nextleaf Solutions (C:OILS*CA)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.